The impact of COVID-19 public health measures on the utilization of antipsychotics in schizophrenia in Manitoba - A population-based study.

Mina ShirinbakhshmasolehLaila AboulattaChristine LeongHayley RielKun LiuJoseph C DelaneyJames M BoltonJamison FalkSilvia Alessi-SeveriniSherif EltonsyKaarina Kowalec

Published in: Schizophrenia research (2024)

This study found a decline in the receipt of antipsychotics for people with SCZ during the initial implementation of COVID-19 public health measures, particularly on the overall incidence. Future work on investigating the impact of these trends on SCZ outcomes is needed to inform future pandemic-related policies.

Keyphrases

public health
coronavirus disease
sars cov
current status
bipolar disorder
respiratory syndrome coronavirus
global health
healthcare
risk factors
quality improvement
type diabetes
metabolic syndrome
adipose tissue
insulin resistance
drug induced